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Here, we report a colonic gastrointestinal stromal tumor (GIST) in a middle-aged man
above 40.  A histologically similar second tumor was detected 2 years after initial surgery.
The primary GIST, measuring 5.5 × 6.0 cm, consisted of spindle tumor cells with a
higher number of mitoses and Ki67 labeling index (about 20%) than those of the second
tumor, implying a de novo GIST.  These markers might be useful in evaluating malignant
potential, as well as to differentiate between a de novo and a recurrent tumor in the
colonic GIST.
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Gastrointestinal stromal tumors (GISTs) are the
most common mesenchymal tumors of the
gastrointestinal (GI) tract.  They are defined as
c-kit (CD117, stem cell factor receptor)-
positive mesenchymal spindle or epithelioid
tumor cells in the GI tract.  GISTs are most
common in the stomach (60–70%), followed by
the small intestine (20–25%).  Colorectal
GISTs are relatively rare, frequency being re-
ported at approximately 5% (Miettinen and
Lasota, 2001).  Moreover, the pathobiological
features of malignant GISTs of the colon re-
main unclear.  Here, we report a case of malig-
nant GISTs which developed in the transverse
colon and the ascending colon, the latter being
detected 2 years after initial surgery.  We ana-
lyzed the number of mitoses and Ki67 labeling
cells in the primary and second GISTs.
Patient Report
The patient was a man in his mid-40’s who
noticed an abdominal tumor without abdominal
pain about 4 years ago.  Abdominal ultrasonog-
raphy did not reveal significant findings at that
time.  A colonic tumor was detected by a bari-
um contrast enema in February 1999.  The tu-
mor was surgically removed with partial resec-
tion of the transverse colon.  Two years after
surgery, computed tomography revealed the
presence of another tumor in the ascending
colon.  The patient underwent surgery again.
The postoperative course was uneventful and
there has been no clinical evidence of tumor
recurrence since.
Pathological findings
The primary tumor was 5.5 × 6.0 cm found in
the transverse colon, whereas the second tumor
was 3.0 × 5.3 cm found in the ascending colon.
Grossly, the primary tumor showed irregular
surfaces with areas of hemorrhage but without
ulceration or necrosis (Fig. 1A).  Histologically,
the tumor, from the muscularis propria to the
serosa, consisted predominantly of spindle
shaped cells with an eosinophilic cytoplasm and
mild nuclear atypia.  No skeinoid fibers or epi-
thelioid cells were observed.  In addition, the
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tumor did not show metastases to the regional
lymph nodes nor lymphatic invasion.  The sec-
ond tumor showed similar pathological find-
ings.  Mitotic figures were relatively frequent
[5/50 high power fields (HPFs)] in the primary
tumor (Fig. 1B), but less frequent in the second
tumor.
Immunohistochemically, most tumor cells
in both lesions were positive for CD117 (Fig.
1C) and vimentin, in contrast to no immuno-
reactivity for CD34, human muscle actin, α-
smooth muscle actin, desmin, S100 protein,
neuron specific enolase (NSE) or epithelial
membrane antigen (EMA).  Both tumors were
Figs. 1A–D.
A:  Gastrointestinal stromal tumor.  Tumor is brownish and well circumscribed, and located from the
muscularis to the serosa of the transverse colon.
B:  Gastrointestinal stromal tumor.  Formalin-fixed, paraffin-embedded tissue section of the tumor in the
transverse colon shows spindle cells possessing mild nuclear atypia and clear nucleoli.  Mitotic figure is
noted (arrow) (hematoxylin and eosin stain; original magnification × 100).
C:  Immunohistochemistry for CD117.  CD117 immunoreactivity is shown in the cytoplasm of tumor cells
(hematoxylin counterstain; original magnification × 200).
D:  Immunohistochemistry for Ki67.  Tumor cells show nuclear immunoreactivity for Ki67 (hematoxylin
counterstain; original magnification × 200).
diagnosed as GIST from the point of histo-
pathological and immunohistochemical find-
ings.  In the primary tumor, nuclear immuno-
reactivity for Ki67 was observed in approxi-
mately 20% of tumor cells (Fig. 1D).  On the
other hand, only 5% of tumor cells were posi-
tive in the second tumor, which showed similar
pathological findings with the primary, except
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Discussion
Here, we describe a case of GIST in the trans-
verse colon, followed by a second tumor in the
ascending colon 2 years after initial surgery.
The second GIST was smaller in size, and had a
lower number of Ki67 labeling cells and mito-
ses than the primary tumor, implying a more
static nature and lower malignant potential in
the former than in the latter.  These pathological
findings promptly raised the question of wheth-
er the tumor localized in the ascending colon
was truly recurrent or de novo developed GIST.
It is well known that the most common sites for
metastases of malignant GISTs are in the liver
and peritoneum.  These metastases can develop
for as long as 30 years after the removal of
GISTs as well as gastrointestinal leiomyosarco-
mas (Salmela, 1968; Ng et al., 1992; Rosai,
1996).  In this case, the primary tumor did not
show metastases to the regional lymph nodes
nor lymphatic invasion.  In addition, the observ-
ed pathological findings were similar, and the
term until the clinical detection of the second
tumor was relatively short, which suggested
that the tumor might be de novo.
Rosai (1996) classified GISTs in the follow-
ing 4 categories; (i) smooth muscle, (ii) neural,
(iii) combined and (iv) uncommitted.  The pres-
ent case showed neither smooth muscle nor
neural differentiation by immunohistochemis-
try.  Therefore, the primary and second tumors
were classified as the uncommitted type.  Al-
though GIST is a mesenchymal tumor of the GI
tract, colorectal GISTs are relatively uncommon
(Miettinen et al., 1995; Miettinen and Losota,
2001).  Miettinen et al. (2000) reported 37
GISTs of the colon, of which 11 cases showed
recurrence or metastasis.  In these 11 cases, the
mean age was 59.2, and the descending colon
was the most frequent site, followed by the
sigmoid colon and the cecum.  In 4 cases out of
the 11, extremely frequent mitotic figures, more
than 100 in 50 HPFs, were observed.  More-
over, liver metastasis was noted in 6 cases.  Re-
currence in the colon was not reported.  On the
other hand, the present case differs from the
report on a few points.  The GIST was located in
the transverse colon and occurred in a middle-
aged man.
Previous studies indicated that the prolifera-
tive index evaluated by Ki67 antigen in the nu-
clei of the tumor cells was the most important
predictor of clinical behavior in GISTs (Carrillo
et al., 1997; Seidal and Edvardsson, 1999).
However, GISTs of the transverse colon have
not been evaluated enough.  We confirmed that
about 20% of tumor cells showed Ki67 expres-
sion in the primary tumor, suggesting that pri-
mary GIST might have possessed high prolifer-
ative activity compared to the second tumor.
Similar to Ki67 expression, high mitotic figures
and tumor size might be also considered to be
aggressive factors in GISTs (Amin et al., 1993;
Rosai, 1996).  According to Amin et al. (1993),
malignant gastric stromal tumors were greater
than 5/50 HPFs in mitotic count and more than
5 cm in size.  Moreover, previous studies dem-
onstrated a significant correlation between the
mitotic count and proliferative nuclear antigen
index or Ki67 index (Amin et al., 1993; Seidal
and Edvardsson, 1999).  The present case show-
ed a higher number of mitotic figures (5/50
HPFs) and Ki67 labeling tumor cells in the pri-
mary GIST.  These factors might also be appli-
cable to GISTs of the transverse colon and use-
ful in evaluating malignant potentials.
In summary, we described a case of malig-
nant GIST of the transverse colon and compar-
ed it with a second tumor from a pathobiol-
ogical viewpoint.  The primary GIST showed a
larger size and consisted of spindle tumor cells
with a higher number of mitoses and Ki67 la-
beling index than those of the second tumor,
implying a de novo development.
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